US 11897969
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11897969 (Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury) held by The Regents of the University of California expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/39583